Found many articles that there is always a pre-treatment before injecting the LPS (in mouse), but how can this data be interpreted considering the real status of a patient, who can't have a pre-treatment like this.
If you are referring to sonication as pretreatment,it is necessary to ensure that the LPS is broken down sufficiently to pass through easily and also prevent clump formation.This has nothing to do with clinical cases.In fact CLP model represent clinical cases better than LPS endotoxemia.
I think the question refers to treatment with glucosamine or another agent to make the mouse more sensitive to LPS (endotoxin). Mice can tolerate mg of LPS, while humans become ill (fever, etc) with doses in ng/kg.